Newsroom

Sorted by: Latest

-

Riassunto: RoslinCT e Ayrmid Ltd. annunciano l'espansione della collaborazione strategica per produrre Omisirge® (omidubicel-onlv) per la seconda indicazione approvata dall'FDA nell'anemia aplastica grave (SAA)

BOSTON--(BUSINESS WIRE)--Ayrmid Ltd., la società madre di Gamida Cell Inc., un pioniere nelle terapie cellulari che lavora per trasformare le cellule in potenti terapie e RoslinCT, un'organizzazione di sviluppo e produzione a contratto di terapie cellulari e geniche, oggi hanno annunciato l'espansione della loro collaborazione strategica per includere l'esecuzione di un accordo di fornitura commerciale a supporto della produzione di Omisirge® (omidubicel-onlv). Il testo originale del presente a...
-

RoslinCT et Ayrmid Ltd. annoncent l’élargissement de leur partenariat stratégique pour la fabrication d’Omisirge® (omidubicel-onlv) pour une deuxième indication approuvée par la FDA dans le traitement de l’anémie aplasique sévère (AAS)

BOSTON--(BUSINESS WIRE)--Ayrmid Ltd., société mère de Gamida Cell Inc., une société pionnière dans le domaine de la thérapie cellulaire qui transforme les cellules en puissants traitements thérapeutiques, et RoslinCT, leader mondial dans le développement et la fabrication sous contrat de thérapies cellulaires et géniques, ont annoncé aujourd’hui l’extension de leur partenariat stratégique afin d’inclure la signature d’un accord d’approvisionnement commercial visant à soutenir la production d’Om...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF- August 15.12.2025 GAUG LN IE000TGSG3Y5  650,002.00 USD  22,788,322.88   35.059  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Scarce Resources UCTS ETF 15.12.2025 SCAR LN IE000BW2B3J3   25,002.00 USD    670,458.60   26.816  ...
-

Vox AI Partners with Adyen to Bring Payments to Drive-Thru Order Terminals

AMSTERDAM--(BUSINESS WIRE)--Vox AI Partners with Adyen to Bring Payments to Drive-Thru Order Terminals...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share FIRST TRUST INDXX FUTURE ECONOMY METALS UCITS ETF 15.12.2025 METL LN IE000UDFKE13   75,002.00 USD   2,267,444.93   30.232  ...
-

Globalstar and Skydio Complete First Drone Flight on Globalstar Band n53TM and XCOM RAN

COVINGTON, La.--(BUSINESS WIRE)--Globalstar (NASDAQ: GSAT), a next-generation telecommunications infrastructure and technology provider, today announces the successful completion of a joint technology trial with Skydio, the leading U.S. drone manufacturer and world leader in autonomous flight. The companies validated compatibility between the Skydio X10 and Globalstar’s licensed Band n53 spectrum, as well as Globalstar’s XCOM RAN private 5G platform. Skydio and Globalstar’s trial evaluated Band...
-

Bluepeak Expands Investment in South Dakota Broadband Infrastructure, Announcing Plans for an Additional $150 Million Multi-Year, Fiber-To-The-Home (FTTH) Expansion Phase

SIOUX FALLS, S.D. & RAPID CITY, S.D.--(BUSINESS WIRE)--Bluepeak today announced significant momentum in its mission to deliver fast, reliable fiber internet to more homes and businesses across South Dakota. To date, the company has invested more than $95 million into South Dakota to build 100% FTTH broadband access to approximately 55,000 residents and businesses in Sioux Falls, Rapid City, Vermillion, and surrounding communities. In addition to its FTTH build, Bluepeak has expanded its multi-s...
-

Elation Health 2025 Year-End Highlights: Growth, Platform Expansion, and Real-World Impact

SAN FRANCISCO--(BUSINESS WIRE)--Elation Health, the clinical‑first technology company powering innovation in primary care, today celebrated 2025 key growth milestones, including accelerated innovation, clinician adoption, and recognition. “2025 showed what’s possible for primary care,” said Kyna Fong, Ph.D., co-founder and CEO of Elation Health. “We began the year earning Best in KLAS for our EHR/PM platform, the first year we were eligible since the integration of our Billing system, and carri...
-

The Boston Globe Names CCC a Top Place to Work in Massachusetts for the Fifth Year in a Row

DANVERS, Mass.--(BUSINESS WIRE)--CCC (Copyright Clearance Center), a pioneer in voluntary collective licensing, has been named one of the Top Places to Work in Massachusetts for the fifth year in a row as part of the 18th annual employee-based survey project from The Boston Globe. CCC was ranked #13 in the Top Large Employers category. According to The Boston Globe, Top Places to Work recognizes the most admired workplaces in the state, voted on by the people who know them best — their employee...